Introduction: Epicardial ablation is becoming an important part of management in patients with ventricular tachycardia (VT). Posterior epicardial access via the Sosa or needle-in-needle (NIN) approach for epicardial VT ablation is considered to be the method of choice for most electrophysiologists. Anterior epicardial access as an alternative technique has recently been proposed, but there are limited data about its safety, efficacy, and the rate of immediate complications. In this study, we report our experience with anterior epicardial access between 2009 and 2016.
INTRODUCTION
Ventricular tachycardia (VT) often complicates later stages of structural heart disease and is an important cause of sudden cardiac arrest. 1 Over the last decade, catheter ablation has emerged as an important option to treat sustained VT and has significantly improved the outcome of patients with VT. Despite advances in endocardial catheter ablation techniques, electroanatomic mapping, and imaging, VT recurrence is still common, especially in complex nonischemic substrates such as arrhythmogenic right ventricular dysplasia (ARVD/C) and sarcoidosis. One of the reasons for failure of endocardial ablation is the presence of epicardial reentrant circuits, which are not easily accessed via the endocardial approach. In the 1990s, Sosa et al. described the cardiomyopathies. [3] [4] [5] [6] [7] [8] While success rates for epicardial ablation have improved outcomes, 3 the associated complication rates continue to range between 4% and 10%, 3, 9 including significant pericardial bleeding, inadvertent right ventricular (RV) puncture, and emergent cardiac surgery.
Anatomically, a potential window exists lateral and just beneath the xyphoid bone where puncturing may directly access the fibrous pericardium without going through the diaphragm. 10 This so called "Anterior approach" to epicardial access is performed via puncturing this potential space. Additionally, consistent with Archimedes' principle of buoyancy, increased accumulation of pericardial fluid has been noted in the region anterior to the right ventricle (RV) of nonsurgical hearts in the supine position. 11, 12 In the supine position, the pericardial fluid tends to accumulate anteriorly. Gale et al. showed in a series of 68 patients with pericardial effusion that the fluid was located solely or predominantly anterior to the RV. Additionally, heart muscle is relatively heavier than normal saline and effusion. Therefore, in the supine position, this forces the fluid anteriorly (Fig. S1A) . The increased pericardial fluid in the anterior part of RV may facilitate easier and safer anterior epicardial access; however, this has not been reported.
In this report, we describe in detail the anterior approach to pericardial access in 103 consecutive patients undergoing epicardial VT ablation. A secondary goal is to compare the success of access and the complications associated with this approach to the published literature on the posterior approach. We hypothesized that an anterior pericardial approach in combination with a preprocedural contrast-enhanced high-resolution cardiac computed tomography (CT) or cardiac magnetic resonance imaging (CMR) may yield fewer complications while maintaining a high success rate.
METHODS

Study population
One hundred and three consecutive patients with structural heart disease who were referred for electrophysiology study and ablation of ventricular arrhythmias using an endo-epicardial approach between 2009 and 2016 were included in this study. In all patients, epicardial access was a planned procedure and the majority of patients failed at least one prior endocardial ablation. All patients had periprocedural imaging either with multidetector computed tomography (MDCT) or magnetic resonance imaging (CMR). We retrospectively compared their outcomes to two previously reported series of patients who underwent epicardial access using the needle-in-needle (NIN) 3 and Sosa 2 techniques. Informed consent was obtained from all patients and the study was approved by the Institutional Review Board at Johns Hopkins Hospital.
Pericardial access
In each of the patients, a preprocedural contrast-enhanced MDCT of the heart or CMR was performed to prospectively evaluate the thoracic anatomy and guide the route for epicardial access (Fig. 1) . Fig. 2A) . In contrast to the NIN approach, 3 a micropuncture needle was not employed. Upon advancing close to the anterior RV silhouette, a few milliliters of contrast medium were injected to demonstrate tenting of the pericardium (Fig. 2B ). Using tactile feedback and fluoroscopic guidance of entry into the pericardial space, the pericardium was punctured. Contrast medium was injected to confirm the position of the needle tip within the pericardial space ( An irrigated ablation catheter (Biosense Webster) was used for epicardial ablation in all patients. Periardium was aspirated through the same sheath every 4 minutes during ablation after interrupting the ablation. The sheaths used in the pericardial space do not allow for air entry; as such, it creates negative pressure as fluid is being aspirated. Following completion of ablation, the pericardium was aspirated to dryness. Methylprednisolone (125 mg) was diluted in 10 mL on normal saline and injected through the Agilis pericardial sheath with the ablation catheter in place to avoid the dead space in the sheath. Following this, the catheter and the sheath were removed en bloc and the skin incision was covered with sterile gauze. Pericardial drain was considered only if continued bleeding occurred with the pericardial fluid continued to be hemorrhagic at the end of the procedure.
Outcomes
The following outcomes in the present study were retrospectively compared with those reported for the NIN and Sosa techniques 3 :
(1) successful epicardial access; (2) incidence of pericardial bleeding, defined as ≥80 mL of estimated pericardial blood loss with or without evidence of tamponade; (3) composite incidence of any other acute or delayed complications related to epicardial access, including subdiaphragmatic vessels, liver, abdominal viscera, or coronary artery injuries. 
Statistical analysis
RESULTS
Baseline characteristics (Table 1)
Of the 103 consecutive patients referred for epicardial VT ablation between 2009 and 2016, preprocedural CT evaluation revealed a long xiphoid process (Fig. 3A) , distended transverse colon (3B-C), or significant hepatomegaly (3D) in 3 patients. Based on these findings, these were deemed not suitable for percutaneous epicardial access (Anterior, NIN, or Sosa techniques) and excluded from our study. Surgical assistance was required to successfully gain epicardial access in these patients.
The final anterior approach series comprised 100 patients ( Table 1 ).
The number of epicardial access procedures gradually increased over the study period (Fig. 4) . Their outcomes were compared with reported outcome of 314 patients who underwent epicardial VT ablation using Sosa (n = 291) or NIN (n = 23) techniques. 3 The anterior approach patients were significantly younger compared with Sosa and NIN series (P = 0.0001). Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) was the most common diagnosis, followed by nonischemic cardiomyopathy, and sarcoidosis in the anterior approach series. No patient had prior cardiac surgery or sternotomy in our series. Ten subjects were on chronic anticoagulation, which was stopped for the procedure. 
Outcomes and complications
The outcomes and complications of pericardial access in this study are shown in Table 2 . Epicardial access was successfully obtained in all patients in the first attempt. We did not observe any significant epicardial bleeding >80 mL in our series. None of the patients who underwent epicardial VT ablation using the anterior approach required urgent/emergent open heart surgery. No procedure related mortality was noted in our cohort of 100 patients.
The rate of successful epicardial access: Epicardial access was successfully obtained in all 100 patients using the anterior approach, which was significantly higher than the Sosa technique (P = 0.012), but it was similar to the NIN technique (P value not significant). Procedure-related mortality 0/100 (0%) 3/297 (1%) 0.31 0/23 (0%) 1 P = 0.046). Sixty-seven percent of the patients were discharged after overnight stay. Self-limiting pericarditis was seen in all patients undergoing VT ablation using anterior approach. Only 2 subjects eventually needed colchicine on discharge. One subject had protracted pericardial pain requiring prolonged hospitalization (5 days). Extensive pericardial injury due to a splayed sheath was suspected to be the underlying cause (Fig. 4D) . The remaining patients were discharged home on nonsteroidal analgesic agents (NSAID). None of the patients required long-term NSAID or colchicine therapy for the management of pericarditis. The rate of pericarditis was not reported in prior case series.
DISCUSSION
The conventional posterior epicardial access aims to enter the pericardium adjacent to the inferior wall. This makes the angle of entry steeper and hence there is a higher reported risk of injury to the diaphragm and the liver. 10 More recently, an anterior approach for pericardial access has been reported in a few cases of epicardial VT ablation 9 and is gaining significant acceptance. However, little is known about the success and complication rates of the anterior approach compared to the traditional posterior approach during the VT mapping and ablation. In this study, we report our experience with the anterior epicardial access in 100 consecutive patients. In this prospective consecutive series of patients undergoing epicardial VT ablation, anterior epicardial access appears to be feasible and devoid of significant complications.
Posterior epicardial approach for VT ablation has been utilized for more than a decade. In the first series of 3 patients described by Sosa, 2 no complications, including pericardial effusion, were reported. In the extended experience of their group with 215 consecutive patients undergoing epicardial VT ablation using the posterior approach, 5 they reported hemopericardium in 7% of the cases requiring drainage and occlusion of a coronary marginal branch, resulting in a non-Q wave myocardial infarction in one patient. In another multicenter safety study, 13 among 121 patients requiring epicardial VT ablation, posterior epicardial access was associated with 5% acute major complications, including 7 cases of epicardial bleeding and 1 case of coronary stenosis.
In the past few years, the Lariat appendage closure device has been deployed using an anterior pericardial approach in patients with atrial fibrillation. The reported rate of pericardial effusion and bleeding has been relatively high and up to 20% of subjects required pericardiocentesis. 14 These data are hard to extrapolate to the epicardial VT ablations since these are completely different procedures with unique patient populations. Current discussions on epicardial access complications still use data from these studies to assess risks of the epicardial ablation procedure during the VT ablation. As such, epicardial ablation is usually reserved as a last resort in the management of VT.
Our results show a much lower risk of complications using the anterior approach, which may influence the decision making for the patients in favor of an early epicardial ablation strategy.
Most centers use periprocedural MDCT or late gadoliniumenhancement cardiac magnetic resonance (LGE-CMR) imaging for electroanatomic mapping. 15, 16 These imaging modalities are very helpful in delineating the structural relationship of pericardium with other chest and abdominal organs. Our results suggest that integration of subxiphoid space anatomy obtained from these imaging modalities into decision making of epicardial access may decrease the rate of complications from the pericardial access, although this needs to be explored in a separate study.
Another interesting observation in this study was a statistically lower rate of pericardial bleeding in the anterior approach series in comparison to the two other series. Differences in patient characteristics are a possible explanation for this discrepancy. Our study included much younger patients, and the majority of the patients were not on anticoagulants. The LV endocardium was not mapped in all the ARVD/C patients and so no heparin was administered during the procedure, which may have further reduced the bleeding rate. 
LIMITATIONS
This is a single-center study primarily in younger patients with nonischemic cardiomyopathy without prior cardiac surgery. The younger age of patients in this cohort is partially due to higher number of ARVD/C patients in our study. Similar to the conventional approach, the anterior pericardial approach may be more challenging in postsurgical hearts. The distribution of pericardial fluid in the supine position has been noted to change after cardiac surgery. Further, we performed a retrospective comparison with published reports on the NIN and Sosa techniques. Although these studies were performed at tertiary centers by experienced hands, a direct comparison between anterior and posterior approaches should be performed in future studies.
CONCLUSION
Anterior pericardial approach was successful in all patients after exclusion of a few patients with high-risk anatomy diagnosed on preprocedure CT imaging. Furthermore, there were no major complications associated with anterior epicardial access. These findings are consistent with our hypothesis that anterior epicardial access in nonsurgical hearts may be facilitated by the anteriorly distributed pericardial fluid in the supine position. Overall, anterior epicardial approach is safe and effective for ablation of VT.
Potential complications may be avoided by preprocedural imaging evaluation.
